Sage Therapeutics, Inc

(NASDAQ:SAGE)

Latest On Sage Therapeutics, Inc (SAGE):

Date/Time Type Description Signal Details
2023-05-09 17:58 ESTNewsSage Therapeutics: Mid-2023 Data Readout And Possible FDA Approval Make This A Must WatchN/A
2023-05-03 02:24 ESTNewsSage Therapeutics, Inc. (SAGE) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 14:08 ESTNewsSage Therapeutics GAAP EPS of -$2.46 beats by $0.06, revenue of $3.3M beats by $1.02MN/A
2023-05-01 13:35 ESTNewsSage Therapeutics Q1 2023 Earnings PreviewN/A
2023-03-13 18:37 ESTNewsSage upgraded to outperform at RBC on greater confidence in zuranolone approvalN/A
2023-03-08 15:36 ESTNewsFDA to not hold panel meeting for Biogen, Sage's depression therapy zuranoloneN/A
2023-02-22 17:22 ESTNewsSage's therapy for Huntington's disease gets orphan drug status in EUN/A
2023-02-21 15:46 ESTNewsSage Therapeutics Looking To FDA Approval Of ZuranoloneN/A
2023-02-16 18:12 ESTNewsSage Therapeutics mixed Q4 earnings; initiates FY23 outlookN/A
2023-02-16 18:12 ESTNewsSage Therapeutics, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-16 18:12 ESTNewsSage Therapeutics, Inc. (SAGE) Q4 2022 Earnings Call TranscriptN/A
2023-02-06 08:46 ESTNewsBiogen, Sage win FDA priority review for depression therapyN/A
2023-01-10 13:49 ESTNewsSage Therapeutics sees depression treatment zuranolone hitting the market as early as Q3N/A
2022-12-13 11:39 ESTNewsSage Therapeutics Could Be In For A Depressing FDA ReviewN/A
2022-12-10 15:56 ESTNewsSage Therapeutics: Zuranolone NDA Near-Term TailwindN/A
2022-12-07 00:56 ESTNewsSage, Biogen complete rolling filing with FDA for depression therapy zuranoloneN/A
2022-11-08 18:43 ESTNewsSage Therapeutics GAAP EPS of -$2.31 misses by $0.11, revenue of $1.74M beats by $0.08MN/A
2022-11-08 18:42 ESTNewsSage Therapeutics, Inc. (SAGE) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 15:03 ESTNewsSage Therapeutics appoints Laura Gault as Chief Medical OfficerN/A
2022-08-02 20:37 ESTNewsSage Therapeutics GAAP EPS of -$2.13 beats by $0.02, revenue of $1.5M misses by $0.27MN/A
2022-08-02 20:37 ESTNewsSage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-01 15:32 ESTNewsSage Therapeutics Q2 2022 Earnings PreviewN/A
2022-06-13 12:22 ESTNewsBiogen, Sage to submit a single marketing application for depression candidateN/A
2022-06-01 20:21 ESTNewsBiogen/Sage's zuranolone helps reduce postpartum depression symptoms, meets main goal of trialN/A
2022-05-03 20:09 ESTNewsSage Therapeutics GAAP EPS of -$2.07 misses by $0.04, revenue of $1.58M misses by $1.65MN/A
2022-05-03 20:09 ESTNewsSage Therapeutics, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-03 20:09 ESTNewsSage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 01:57 ESTNewsSage Therapeutics Q1 2022 Earnings PreviewN/A
2022-05-02 08:38 ESTNewsSage, Biogen begin rolling submission with FDA for zuranolone to treat depressionN/A
2022-04-01 11:49 ESTNewsSage stock rises 15% as drug shows function/learning benefit in Alzheimer’s patients with dementiaN/A
2022-03-30 23:35 ESTNewsSage Therapeutics (SAGE) presents at 2022 Stifel CNS Days - SlideshowN/A
2022-03-24 23:14 ESTNewsSage Therapeutics: Well-Funded But Uninspiring DataN/A
2022-03-15 09:02 ESTNewsSage Therapeutics drug benefits cognitive function in phase 2 trial in Parkinson’sN/A
2022-03-01 12:26 ESTNewsSage Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-24 18:37 ESTNewsSage Therapeutics GAAP EPS of -$2.12 beats by $0.05, revenue of $1.6M misses by $0.17MN/A
2022-02-24 18:36 ESTNewsSage Therapeutics' (SAGE) CEO Barry Greene on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 01:32 ESTNewsSage Therapeutics Q4 2021 Earnings PreviewN/A
2022-02-17 03:14 ESTNewsSage, Biogen announce late-stage trial for depression therapy met key goalsN/A
2022-02-01 14:17 ESTNewsNew thematic psychedelic ETF hits the marketN/A
2022-01-13 04:09 ESTNewsSage Therapeutics (SAGE) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-04 02:08 ESTNewsSage Therapeutics: Biogen's Backing May See It ThroughN/A
2021-12-08 12:43 ESTNewsSage Therapeutics, Biogen reports new analyses from Landscape program of zuranolone in MDDN/A
2021-12-01 08:17 ESTNewsSage Therapeutics, Biogen report positive zuranolone data in late-stage depression studyN/A
2021-11-02 22:49 ESTNewsSage Therapeutics EPS misses by $0.36, misses on revenueN/A
2021-11-02 22:49 ESTNewsSage Therapeutics posts Q3 earnings miss, pipeline updateN/A
2021-11-02 22:48 ESTNewsSage stock hits 52-week low as departure of medical chief follows earnings missN/A
2021-11-02 22:47 ESTNewsSAGE Therapeutics, Inc. (SAGE) CEO Barry Greene on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-02 22:47 ESTNewsSage Therapeutics, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-02 03:24 ESTNewsSage Therapeutics Q3 2021 Earnings PreviewN/A
2021-10-19 17:36 ESTNewsBiogen, Sage expect marketing application for depression therapy in H2 2022N/A

About Sage Therapeutics, Inc (SAGE):

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, bipolar depression, and generalized anxiety disorders; and SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases. In addition, its product pipeline comprises SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which has completed Phase I clinical trial for the treatment of depression, Huntington's disease, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. Sage Therapeutics, Inc. has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

See Advanced Chart

General

  • Name Sage Therapeutics, Inc
  • Symbol SAGE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 298
  • Fiscal Year EndDecember
  • IPO Date2014-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.sagerx.com
View More

Valuation

  • Trailing PE 6.57
  • Price/Sales (Trailing 12 Mt.) 3.76
  • Price/Book (Most Recent Quarter) 2.23
  • Enterprise Value Revenue 2.28
  • Enterprise Value EBITDA 4.05
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$7.73
  • Next Year EPS Estimate -$6.01
  • Next Quarter EPS Estimate $0.75
  • Profit Margin 54%
  • Operating Margin 56%
  • Return on Assets 24%
  • Return on Equity 40%
  • Revenue 1.11 billion
  • Earnings Per Share $11.43
  • Revenue Per Share $21.43
  • Gross Profit 820.92 million
  • Quarterly Earnings Growth 56491.1%
View More

Highlights

  • Market Capitalization 4.38 billion
  • EBITDA 626.6 million
  • PE Ratio -1.15
  • PEG Ratio 0.74
  • Analyst Target Price $102.21
  • Book Value Per Share $35.54
View More

Share Statistics

  • Shares Outstanding 58.38 million
  • Shares Float 51.18 million
  • % Held by Insiders 161%
  • % Held by Institutions 93.8%
  • Shares Short 5.2 million
  • Shares Short Prior Month 5.1 million
  • Short Ratio 10.41
  • Short % of Float 12%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 2.05
  • 52 Week High $98.39
  • 52 Week Low $25.25
  • 50 Day Moving Average 80.49
  • 200 Day Moving Average 74.68
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Sage Therapeutics, Inc (SAGE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sage Therapeutics, Inc (SAGE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$1.11 billion$18.19-$2.12959.26%
2020-09-302020-11-05$1.64 million-$2.04-$2.4717.25%
2020-06-302020-08-10$N/A-$2.08-$2.5919.67%
2020-03-312020-05-07$2.29 million-$2.44-$3.1722.99%
2019-12-312020-02-27$1.96 million-$3.25-$3.6310.53%
2019-09-302019-11-12$3.57 million-$3.48-$3.38-3.02%
2019-06-302019-08-06$873000-$3.28-$3.352.04%
2019-03-312019-05-02$465000-$3.37-$3.19-5.73%
2018-12-312019-02-19$273000-$3.38-$2.92-15.89%
2018-09-302018-11-06$-90000000-$2.63-$2.40-9.38%
2018-06-302018-08-07$90 million-$0.36-$1.8280.24%
2018-03-312018-05-03$N/A-$1.68-$1.817.31%
2017-12-312018-02-22$N/A-$1.75-$2.0113.1%
2017-09-302017-11-02$N/A-$1.97-$1.93-2.03%
2017-06-302017-08-03$N/A-$1.88-$1.63-15.05%
2017-03-312017-05-09$N/A-$1.52-$1.551.94%
2016-12-312017-02-23$N/A-$1.50-$1.17-27.79%
2016-09-302016-11-03$N/A-$1.15-$1.09-5.49%
2016-06-302016-08-09$N/A-$1.08-$1.01-7.16%
2016-03-312016-05-05$N/A-$0.97-$0.970%
2015-12-312016-02-24$N/A-$0.99-$0.94-5.34%
2015-09-302015-11-05$N/A-$0.84-$0.83-1.2%
2015-06-302015-08-12$N/A-$0.90-$0.68-32.35%
2015-03-312015-05-14$N/A-$0.66-$0.49-34.69%
2014-12-312015-02-27$N/A-$0.57-$0.43-32.56%
2014-09-302014-11-11$N/A-$0.50-$0.40-25%
2014-06-302014-08-14$N/A-$4.57-$1.23-271.54%

Sage Therapeutics, Inc (SAGE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Sage Therapeutics, Inc (SAGE) Chart:

Sage Therapeutics, Inc (SAGE) News:

Below you will find a list of latest news for Sage Therapeutics, Inc (SAGE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sage Therapeutics, Inc (SAGE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-172.50CALL0 0426.74TRUE00
2025-04-1750CALL0 0372.58TRUE00
2025-04-177.51.15CALL23 17094.83TRUE-0.15-0.12
2025-04-17100.1CALL2 110273.07FALSE-0.04-0.29
2025-04-1712.50CALL0 0117.7FALSE00
2025-04-17150CALL0 0154.65FALSE00
2025-04-172.50PUT0 0267.64FALSE00
2025-04-1750.1PUT0 1122.77FALSE00
2025-04-177.50.24PUT0 1451.52FALSE00
2025-04-17100PUT0 0147.23TRUE00
2025-04-1712.50PUT0 0245.42TRUE00
2025-04-17150PUT0 0254.68TRUE00
2025-05-162.50CALL0 0266.01TRUE00
2025-05-1652.95CALL0 50162.12TRUE00
2025-05-167.51.45CALL0 135179.82TRUE00
2025-05-16100.2CALL4 154657.81FALSE-0.07-0.26
2025-05-1612.50.85CALL0 1973.59FALSE00
2025-05-16150.05CALL0 5159.02FALSE00
2025-05-162.50.09PUT0 2168.82FALSE00
2025-05-1650.15PUT0 31197.49FALSE00
2025-05-167.50.2PUT30 196444.68FALSE0.20
2025-05-16102.55PUT0 21154.34TRUE00
2025-05-1612.57.6PUT0 0238.8TRUE00
2025-05-16150PUT0 0179.25TRUE00
2025-08-152.55CALL0 0259.6TRUE00
2025-08-1553.6CALL0 1127.98TRUE00
2025-08-157.51.15CALL0 117161.06TRUE00
2025-08-15100.65CALL0 187048.71FALSE00
2025-08-1512.50.15CALL0 1342.4FALSE00
2025-08-15150CALL0 0125.08FALSE00
2025-08-152.50PUT0 0113.01FALSE00
2025-08-1550.3PUT0 1889.9FALSE00
2025-08-157.50.42PUT0 21562.19FALSE00
2025-08-15103.2PUT0 3101.05TRUE00
2025-08-1512.50PUT0 0144.35TRUE00
2025-08-15150PUT0 0165.1TRUE00
2025-11-212.50CALL0 0164.83TRUE00
2025-11-2150CALL0 062.46TRUE00
2025-11-217.50CALL0 052.33TRUE00
2025-11-21100CALL0 064.19FALSE00
2025-11-2112.50.2CALL20 2041.08FALSE0.20
2025-11-21150CALL0 094.94FALSE00
2025-11-212.50PUT0 0238.47FALSE00
2025-11-2150PUT0 096.5FALSE00
2025-11-217.50PUT0 060.65FALSE00
2025-11-21100PUT0 087.21TRUE00
2025-11-2112.50PUT0 0113.54TRUE00
2025-11-21150PUT0 0130.06TRUE00
2026-01-162.54.82CALL0 5170.59TRUE00
2026-01-1652.78CALL0 762131.83TRUE00
2026-01-167.51.57CALL0 26446.07TRUE00
2026-01-16100.91CALL0 73243.49FALSE00
2026-01-1612.50.35CALL98 35843.94FALSE0.350
2026-01-16150.45CALL0 6885.84FALSE00
2026-01-1617.50.05CALL0 9095.18FALSE00
2026-01-16200.1CALL0 13866.2FALSE00
2026-01-1622.50.5CALL0 24110.52FALSE00
2026-01-16250.05CALL0 2691.92FALSE00
2026-01-1627.51CALL0 2796.87FALSE00
2026-01-16300.1CALL0 3886.23FALSE00
2026-01-1632.50.17CALL0 6130.81FALSE00
2026-01-16350.1CALL0 15134.65FALSE00
2026-01-1637.50CALL0 0138.17FALSE00
2026-01-16400.07CALL0 17776.52FALSE00
2026-01-162.50.1PUT0 285.56FALSE00
2026-01-1650.23PUT0 84371.85FALSE00
2026-01-167.51.2PUT0 3944.72FALSE00
2026-01-16102.15PUT0 1537.02TRUE00
2026-01-1612.50PUT0 0110.46TRUE00
2026-01-16158.92PUT0 0139.32TRUE00
2026-01-1617.59.6PUT0 0147.99TRUE00
2026-01-16208PUT0 0161.51TRUE00
2026-01-1622.510.8PUT0 0166.77TRUE00
2026-01-162512PUT0 0177.88TRUE00
2026-01-1627.59PUT0 0184.77TRUE00
2026-01-16300PUT0 0191.04TRUE00
2026-01-1632.50PUT0 0196.76TRUE00
2026-01-16350PUT0 0202.01TRUE00
2026-01-1637.50PUT0 0206.86TRUE00
2026-01-16400PUT0 0211.39TRUE00
2027-01-152.50CALL0 0118.03TRUE00
2027-01-1553.1CALL0 1243.01TRUE00
2027-01-157.52.5CALL0 1619.02TRUE00
2027-01-15101.23CALL0 871.4FALSE00
2027-01-1512.51.01CALL0 178.24FALSE00
2027-01-15150.05CALL0 8260.18FALSE00
2027-01-152.50.4PUT0 574.7FALSE00
2027-01-1551PUT0 658.85FALSE00
2027-01-157.51PUT0 256.34FALSE00
2027-01-15100PUT0 038.88TRUE00
2027-01-1512.54.03PUT0 8031.15TRUE00
2027-01-15150PUT0 0100.16TRUE00

Latest SAGE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST10$32
Jun 13, 2022 7:59 PM EST7$31.98
Jun 13, 2022 7:59 PM EST37$31.98
Jun 13, 2022 7:59 PM EST100$31.98
Jun 13, 2022 7:59 PM EST1$31.99

Sage Therapeutics, Inc (SAGE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004431/0001562180-20-004431-index.htm
2020-07-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1597553/000000000020006722/0000000000-20-006722-index.htm
2020-09-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1597553/000000000020008250/0000000000-20-008250-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000008025519002669/0000080255-19-002669-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000008025520000011/0000080255-20-000011-index.htm
2020-04-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000008025520001438/0000080255-20-001438-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000021545719005781/0000215457-19-005781-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000031506619001342/0000315066-19-001342-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000031506620001221/0000315066-20-001221-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000083423720006703/0000834237-20-006703-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000089924319003668/0000899243-19-003668-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000093247119006113/0000932471-19-006113-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000110465920017946/0001104659-20-017946-index.htm
2018-12-18S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1597553/000119312518352130/0001193125-18-352130-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519003129/0001193125-19-003129-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519014879/0001193125-19-014879-index.htm
2019-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519043460/0001193125-19-043460-index.htm
2019-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1597553/000119312519043509/0001193125-19-043509-index.htm
2019-02-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1597553/000119312519049853/0001193125-19-049853-index.htm
2019-02-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1597553/000119312519052905/0001193125-19-052905-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519052913/0001193125-19-052913-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519053991/0001193125-19-053991-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519079860/0001193125-19-079860-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1597553/000119312519119608/0001193125-19-119608-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1597553/000119312519119616/0001193125-19-119616-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519133822/0001193125-19-133822-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519167248/0001193125-19-167248-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519173095/0001193125-19-173095-index.htm
2019-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519200528/0001193125-19-200528-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519213484/0001193125-19-213484-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519289188/0001193125-19-289188-index.htm
2019-12-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519306717/0001193125-19-306717-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520050968/0001193125-20-050968-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1597553/000119312520051038/0001193125-20-051038-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520076535/0001193125-20-076535-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520100489/0001193125-20-100489-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1597553/000119312520124472/0001193125-20-124472-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1597553/000119312520124474/0001193125-20-124474-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520136314/0001193125-20-136314-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520165675/0001193125-20-165675-index.htm
2020-08-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1597553/000119312520208158/0001193125-20-208158-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520214068/0001193125-20-214068-index.htm
2020-08-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1597553/000119312520225608/0001193125-20-225608-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520261295/0001193125-20-261295-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520269896/0001193125-20-269896-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520286184/0001193125-20-286184-index.htm
2018-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218018004912/0001562180-18-004912-index.htm
2018-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218018004913/0001562180-18-004913-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000187/0001562180-19-000187-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000252/0001562180-19-000252-index.htm
2019-01-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000487/0001562180-19-000487-index.htm
2019-01-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000488/0001562180-19-000488-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000489/0001562180-19-000489-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000490/0001562180-19-000490-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000858/0001562180-19-000858-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000994/0001562180-19-000994-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001008/0001562180-19-001008-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001029/0001562180-19-001029-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001030/0001562180-19-001030-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001031/0001562180-19-001031-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001032/0001562180-19-001032-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001033/0001562180-19-001033-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001034/0001562180-19-001034-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001529/0001562180-19-001529-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001850/0001562180-19-001850-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003388/0001562180-19-003388-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003389/0001562180-19-003389-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003390/0001562180-19-003390-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003391/0001562180-19-003391-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003392/0001562180-19-003392-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003393/0001562180-19-003393-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003394/0001562180-19-003394-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003395/0001562180-19-003395-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003636/0001562180-19-003636-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003637/0001562180-19-003637-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003638/0001562180-19-003638-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003639/0001562180-19-003639-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003640/0001562180-19-003640-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003968/0001562180-19-003968-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003969/0001562180-19-003969-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004068/0001562180-19-004068-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004088/0001562180-19-004088-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004089/0001562180-19-004089-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004090/0001562180-19-004090-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004091/0001562180-19-004091-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004092/0001562180-19-004092-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004093/0001562180-19-004093-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004670/0001562180-19-004670-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004788/0001562180-19-004788-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019005990/0001562180-19-005990-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020000275/0001562180-20-000275-index.htm
2020-02-045Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020000855/0001562180-20-000855-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001240/0001562180-20-001240-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001242/0001562180-20-001242-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001243/0001562180-20-001243-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001244/0001562180-20-001244-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001245/0001562180-20-001245-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001246/0001562180-20-001246-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003221/0001562180-20-003221-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003222/0001562180-20-003222-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003223/0001562180-20-003223-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003224/0001562180-20-003224-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003225/0001562180-20-003225-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003226/0001562180-20-003226-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003263/0001562180-20-003263-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003386/0001562180-20-003386-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004425/0001562180-20-004425-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004426/0001562180-20-004426-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004427/0001562180-20-004427-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004428/0001562180-20-004428-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004429/0001562180-20-004429-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004430/0001562180-20-004430-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004431/0001562180-20-004431-index.htm
2020-10-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020006282/0001562180-20-006282-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020006284/0001562180-20-006284-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000156223020000051/0001562230-20-000051-index.htm
2019-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1597553/000156459019003191/0001564590-19-003191-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459019015034/0001564590-19-015034-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459019028984/0001564590-19-028984-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459019042533/0001564590-19-042533-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1597553/000156459020007021/0001564590-20-007021-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459020022891/0001564590-20-022891-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459020038597/0001564590-20-038597-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459020050861/0001564590-20-050861-index.htm
2020-05-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1597553/999999999720003221/9999999997-20-003221-index.htm

Sage Therapeutics, Inc (SAGE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sage Therapeutics, Inc (SAGE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 161%
Institutional Ownership: 9380%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-12KEVIN P STARRDirectorSell0.000.00https://www.sec.gov/Archives/edgar/data/1597553/000089924319003668/0000899243-19-003668-index.htm
2019-05-10Anne Marie CookSVP, GC & SecretarySell15,000.00166.142,492,100.000.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm
2019-05-24JEFFREY M JONASPresident & CEOBuy40,356.000.4518,160.20102,471.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-12-09Albert RobichaudChief Scientific OfficerBuy6,935.001.369,431.60102,592.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-07-17KIMI IGUCHICFO & TreasurerBuy4,000.001.365,440.0010,409.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003969/0001562180-19-003969-index.htm
2019-08-15JAMES M FRATESDirectorBuy8,000.0028.35226,800.0010,535.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm
2019-12-09Albert RobichaudChief Scientific OfficerBuy5,732.0038.25219,249.00108,324.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell4,200.00173.41728,322.00109,704.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-02-15STEVEN M PAULDirectorSell12,519.00161.022,015,809.38111,385.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-12-09Albert RobichaudChief Scientific OfficerBuy3,076.0028.6388,065.88111,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell1,619.00172.20278,791.80113,904.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell500.00171.0185,505.00115,523.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-23JEFFREY M JONASPresident & CEOBuy53,908.000.4524,258.60116,023.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-01-23JAMES M FRATESDirectorBuy7,500.008.9266,900.0011,735.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm
2019-05-29JEFFREY M JONASPresident & CEOSell475.00171.3981,410.5412,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-05-06JAMES M FRATESDirectorBuy8,000.008.9271,360.0012,235.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm
2019-03-21STEVEN M PAULDirectorSell1,967.00161.02316,726.34122,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm
2019-07-25KIMI IGUCHICFO & TreasurerBuy2,000.001.362,720.0012,409.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004068/0001562180-19-004068-index.htm
2019-03-21STEVEN M PAULDirectorSell2,919.00161.05470,104.95124,367.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm
2019-05-29JEFFREY M JONASPresident & CEOSell400.00170.4068,158.0012,590.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-03-21STEVEN M PAULDirectorSell2,993.00161.04481,992.72127,286.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm
2019-05-29JEFFREY M JONASPresident & CEOSell200.00169.1633,832.0012,990.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-03-20STEVEN M PAULDirectorSell13,047.00161.352,105,133.45130,279.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell2,545.00177.62452,033.2313,190.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-12-09Albert RobichaudChief Scientific OfficerBuy25,000.0064.161,604,000.00136,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-03-01KIMI IGUCHICFO & TreasurerSell25,563.00156.934,011,601.591,413.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001529/0001562180-19-001529-index.htm
2019-07-25KIMI IGUCHICFO & TreasurerBuy1,900.0014,309.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004089/0001562180-19-004089-index.htm
2019-03-20STEVEN M PAULDirectorSell13,096.00161.322,112,646.72143,326.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-05-10Anne Marie CookSVP, GC & SecretaryBuy15,000.0028.63429,450.0015,000.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm
2019-03-20STEVEN M PAULDirectorSell16,182.00161.202,608,538.40156,422.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell11,662.00176.442,057,673.6015,735.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-03-20STEVEN M PAULDirectorSell14,321.00161.322,310,263.72172,604.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-18STEVEN M PAULDirectorSell875.00161.01140,883.75186,925.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-18STEVEN M PAULDirectorSell800.00161.02128,816.00187,800.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-18STEVEN M PAULDirectorSell1,200.00161.14193,368.00188,600.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-18STEVEN M PAULDirectorSell900.00161.01144,909.00189,800.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-01STEVEN M PAULDirectorSell700.00161.00112,700.00190,700.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-03-01STEVEN M PAULDirectorSell700.00161.00112,700.00191,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-03-01STEVEN M PAULDirectorSell500.00161.0080,500.00192,100.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-03-01STEVEN M PAULDirectorSell700.00161.00112,700.00192,600.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-08-15JAMES M FRATESDirectorSell8,000.00160.581,284,640.002,535.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm
2019-05-22Michael CloonanChief Business OfficerBuy25,000.0073.431,835,750.0025,461.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm
2019-07-25Anne Marie CookSVP, GC & SecretaryBuy1,900.002,600.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004088/0001562180-19-004088-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell16,651.00175.722,925,880.4227,397.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-07-25Stephen KanesChief Medical OfficerBuy1,900.002,841.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004090/0001562180-19-004090-index.htm
2019-12-09KIMI IGUCHICFO & TreasurerBuy15,000.001.3620,400.0028,761.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm
2019-12-10KIMI IGUCHICFO & TreasurerBuy500.001.36680.0029,261.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm
2019-07-25Michael CloonanChief Business OfficerBuy2,450.003,190.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004093/0001562180-19-004093-index.htm
2020-04-30KIMI IGUCHICFO & TreasurerBuy4,000.001.365,440.0033,261.00https://www.sec.gov/Archives/edgar/data/1597553/000156218020003263/0001562180-20-003263-index.htm
2019-07-16JEFFREY M JONASPresident & CEOBuy27,000.000.4512,150.0039,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003968/0001562180-19-003968-index.htm
2019-01-23JAMES M FRATESDirectorSell7,500.00134.811,011,075.004,235.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm
2019-05-06JAMES M FRATESDirectorSell8,000.00162.221,297,760.004,235.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell28,293.00174.484,936,667.3244,048.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-07-25JEFFREY M JONASPresident & CEOBuy5,000.0044,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004092/0001562180-19-004092-index.htm
2019-05-22Michael CloonanChief Business OfficerSell25,000.00175.004,375,000.00461.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm
2019-09-11JEFFREY M JONASPresident & CEOBuy4,600.000.452,070.0047,030.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004788/0001562180-19-004788-index.htm
2019-12-09JEFFREY M JONASPresident & CEOBuy7,500.0064.20481,500.0054,530.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005990/0001562180-19-005990-index.htm
2019-03-08KIMI IGUCHICFO & TreasurerBuy4,723.000.452,125.356,136.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001850/0001562180-19-001850-index.htm
2019-01-09JEFFREY M JONASPresident & CEOBuy10,000.000.454,500.0062,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019000252/0001562180-19-000252-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell1,763.00176.15310,552.4562,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell950.00177.76168,872.0062,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell2,518.00176.80445,182.4063,065.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell14,727.00175.092,578,550.4363,878.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell3,974.00175.79698,589.4665,583.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell24,966.00175.024,369,549.3269,557.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-10Anne Marie CookSVP, GC & SecretaryBuy700.0056.2739,389.00700.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm
2019-02-25STEVEN M PAULDirectorSell500.00161.0080,500.0070,900.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-02-25STEVEN M PAULDirectorSell500.00161.0080,500.0071,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-02-25STEVEN M PAULDirectorSell500.00161.0080,500.0071,900.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell25,510.00173.624,428,933.9672,341.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-02-25STEVEN M PAULDirectorSell500.00161.0080,500.0072,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-02-19STEVEN M PAULDirectorSell200.00162.0032,400.0072,900.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-19STEVEN M PAULDirectorSell643.00161.37103,760.9173,100.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-19STEVEN M PAULDirectorSell500.00161.6280,812.0073,743.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-19STEVEN M PAULDirectorSell200.00162.0032,400.0074,243.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-15STEVEN M PAULDirectorSell12,388.00161.021,994,715.7674,443.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell31,099.00174.465,425,531.5478,605.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-09-04Stephen KanesChief Medical OfficerBuy6,000.000.452,700.008,292.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004670/0001562180-19-004670-index.htm
2019-02-15STEVEN M PAULDirectorSell12,044.00161.021,939,324.8886,831.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-08Stephen KanesChief Medical OfficerSell22,948.00150.003,442,200.00941.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019000858/0001562180-19-000858-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell7,948.00174.051,383,349.4094,523.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-07-25Albert RobichaudChief Scientific OfficerBuy1,900.0096,205.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004091/0001562180-19-004091-index.htm
2019-05-28JEFFREY M JONASPresident & CEOBuy35,736.000.4516,081.2097,851.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-02-15STEVEN M PAULDirectorSell12,510.00161.022,014,360.2098,875.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm